PROGENICS PHARMACEUTICALS
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for PROGENICS PHARMACEUTICALS COMMON STOCK, CUSIP 30022000 .
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for PROGENICS PHARMACEUTICALS COMMON STOCK, CUSIP 30022000 .